Bayer, the company behind supplement brands Redoxon and Berocca, reported a “significant decline” in its nutritionals category in APAC and other major markets, but the CEO is still confident that sales would “return to healthy growth” for the full year.
Bayer’s maternal nutrition supplement brand, Elevit, has made its debut in the infant nutrition space with new products launched in China last month. Speaking to NutraIngredients-Asia, Bayer Consumer Health China has also outlined the new product pipeline...
Bayer, which owns vitamin brands Redoxon, Berocca, and CDR, has reported “high double digit” online growth in a number of Southeast Asian markets, spurring it to reinforce its digital first strategy in the region.
Bayer has officially launched its consumer health division in India and the German MNC is eyeing penetration into both metro and rural vitamin and mineral supplement (VMS) markets with its reformulated bestseller Supradyn.
Bayer is extending its expertise in gastrointestinal relief to overall gut wellbeing with the launch of two probiotics, developed with China’s Jiangnan University, to tackle constipation and diarrhoea.
Bayer has launched a campaign to better educate parents on nutrition’s role in baby development as a recent survey finds 60% did not know nutrition impacts baby growth and development during pregnancy.
Moving fast and quick is crucial to tap on the “tremendous opportunities” that the South East Asia (SEA) market presents, according to Bayer’s ASEAN head who also spoke about the firm’s recent partnership with an airline and its promotional Tiktok dance...
Bayer Consumer Health has opened its first APAC R&D Center in Qidong, Jiangsu Province in China to cater its products and solutions for Chinese consumers.
